SCHEMBL370836

SCHEMBL370836

Cc1c(C(=O)O)ccc(Cl)c1Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ RHEB Q15382 3/20 0.42
▸ PTGS2 P35354 3/20 0.41
▸ PTGS1 P23219 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ TTR P02766 2/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41
▸ AKR1C3 P42330 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ MT-CO2 P00403 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ PLA2G1B P04054 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ PGR P06401 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4804791 0.86 TDP1 (0.47) ALDH1A1RHEBPTGS2KDM4EHSD17B10
SCHEMBL14920304 0.81 PTGS1 (0.44) ALDH1A1RHEBPTGS2PTGS1KDM4E
SCHEMBL9323062 0.79 LMNA (0.44) ALDH1A1RHEBPTGS2PTGS1KDM4E
SCHEMBL20503300 0.78 RAF1 (0.38) ALDH1A1CYP2C9CYP2C19MEN1AKR1C3
SCHEMBL8406918 0.78 ALDH1A1 (0.57) ALDH1A1PTGS2CYP2C9CYP2C19MEN1
SCHEMBL17689717 0.74 RHEB (0.44) RHEBKDM4EMEN1TTRKMT2A
SCHEMBL11138435 0.74 IDO1 (0.42) ALDH1A1PTGS2PTGS1KDM4EHSD17B10
SCHEMBL9630582 0.73 MEN1 (0.41) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL27544752 0.73 CSNK2A2 (0.49) ALDH1A1PTGS2KDM4ECYP2C9CYP2C19
SCHEMBL31636330 0.72 ALDH1A1 (0.44) ALDH1A1PTGS2KDM4ECYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550746-B2 Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators ALLERGAN, INC. (US) 2017-01-24 — — US disclosed
US-20150218119-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. 2015-08-06 — — US disclosed
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 — — US disclosed
US-8927544-B2 Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators ALLERGAN, INC. (US) 2015-01-06 — — US disclosed
WO-2013130958-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2013-09-06 — — WO disclosed
US-20130231338-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS ALLERGAN, INC. (US) 2013-09-05 — — US disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150218119-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS CXCR2, CCR2, CCR5 ALDH1A1 1991/4885RHEB 3669/4885PTGS2 447/4885
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A ALDH1A1 767/4885RHEB 3294/4885PTGS2 2572/4885
US-20130231338-A1 BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS CXCR2, CCR2, CCR5 ALDH1A1 1991/4885RHEB 3669/4885PTGS2 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback